Jyrki Lehtimäki

Title: Jyrki Lehtimäki: Innovator in Medicinal Chemistry

Introduction

Jyrki Lehtimäki is a notable inventor based in Sauvo, Finland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of analgesic medications. With a total of 3 patents to his name, Lehtimäki's work focuses on innovative methods for pain management.

Latest Patents

One of Jyrki Lehtimäki's latest patents involves the use of 3-(1H-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal, or epidural administration. This invention relates to a method for obtaining analgesia by administering 3-(1H-imidazol-4-ylmethyl)-indan-5-ol, its enantiomer, or a pharmaceutically acceptable ester or salt thereof to a mammal intraspinally. The method allows for the administration of this compound to achieve analgesia without side effects, such as sedation. Additionally, the invention includes the use of the drug as an adjunct to anesthesia by administering it intraspinally.

Career Highlights

Jyrki Lehtimäki is associated with Orion Corporation, a prominent company in the pharmaceutical industry. His work at Orion has allowed him to focus on developing innovative solutions for pain management and anesthesia.

Collaborations

Throughout his career, Jyrki has collaborated with notable colleagues, including Antti Haapalinna and Raimo E Virtanen. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jyrki Lehtimäki's contributions to medicinal chemistry and pain management are noteworthy. His innovative approaches and collaborations have led to significant advancements in the field. His work continues to impact the development of effective analgesic medications.